Norway· NO-ID_FDF48914-C6BA-4C50-8B47-C6B6EF6952F8

Brulidine

A dibrompropamidine product containing dibrompropamidine diisetionate, registered in Norway by Manx. The same ATC class is registered in 2 of our 19 countries.

ATC D08AC01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedBrulidineATCD08AC01REGISTER NO.NO-ID_FDF48914-C6BA-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Dibrompropamidine is registered in 2 of 19 countries.

Countries holding a registration under ATC D08AC01 (dibrompropamidine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 1 of them publish a price we can compare per daily dose

Dibrompropamidine · ATC D08AC01

2 / 19 countries

  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Dibrompropamidine Diisetionate
Manufacturer
Manx
Country
Norway (NO)
ATC code
D08AC01
ATC class
Dibrompropamidine
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_FDF48914-C6BA-4C50-8B47-C6B6EF6952F8
  • no_varenummer
    288165
    25
  • gtin
    5035559014807

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dibrompropamidine in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dibrompropamidine products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Cyprus · Golden Eye
  • United Kingdom (Northern Ireland) · Brolene, Brulidine
  • Ireland · Brolene, Golden Eye
  • Malta · Golden Eye

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7aef17a-33b7-47d0-a056-0bf71cf64e0c
GET /v1/drugs/c7aef17a-33b7-47d0-a056-0bf71cf64e0c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "fest",
  "status": "A",
  "atc_name": "Dibrompropamidin",
  "merkevare_id": "ID_FDF48914-C6BA-4C50-8B47-C6B6EF6952F8",
  "name_form_strength": "Brulidine krem 0,15 % w/w",
  "prescription_group": "C"
}

See everything about dibrompropamidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.